Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avazzia
Dallas, Texas, United Statesavazzia.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Avazzia’s devices are FDA-cleared for prescription and over-the-counter use in the management of acute, chronic, and post-operative pain. Clinical studies have demonstrated their effectiveness in providing non-invasive, drug-free relief for up to 12–24 hours after treatment. The technology is based on patented biofeedback-driven microcurrent stimulation that mimics physiological nerve impulses to modulate pain perception[2][5][6].
- Therapeutic areas
- NeurologyCardiovascular
- Modalities
- DeviceNon-pharmacological therapyBioelectric stimulation device (microcurrent electro-stimulation)
- Industry
- Therapeutic Medical Devices
02
Partnerships
U.S. Department of Veterans Affairs (VA) clinical research collaborations[2]
Beyond the preview
Go deeper on Avazzia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avazzia.